Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Long Beach › NPI 1194840421
Hospital

Dignity Health

Dignity Health was paid $59.98M by Medicaid between Jan 2018 and Dec 2024, across 373 billing codes. Its largest line is 0450, Emergency room services — 36% of everything it billed.

33Billing provider infoDIGNITY HEALTH
LONG BEACH, CA 90813
33aNPI1194840421assigned 03/19/2007
33bProvider typeRehabilitation Hospital Unit
28Total paid$59.98M
24GClaims1,135,652
24DCodes billed373
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rehabilitation Hospital Unit providers in California

Rank by total paid#3 of 22
Median peer was paid$308K
This provider vs. median194×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official MORISSETTE, DANIEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018219,927$8.51M
2019189,353$7.69M
2020126,533$7.44M
2021131,347$8.08M
2022146,108$10.02M
2023167,889$10.32M
2024incomplete154,495$7.91M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 36% 119,430 103,890 $21.79M
0250 10% 42,441 22,310 $6.25M
0301 2.9% 5,828 5,335 $1.75M
0121 2.4% 353 336 $1.44M
70450 Computed tomography, head or brain; without contrast material 1.9% 8,452 8,179 $1.12M
Z7502 1.8% 28,171 27,838 $1.07M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 1.6% 8,577 7,973 $961K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 3,974 3,859 $871K
A9150 Non-prescription drugs 1.4% 5,120 2,695 $829K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.4% 4,965 4,775 $814K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 1.3% 8,891 8,156 $795K
0214 1.3% 228 210 $793K
361 more codes
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.3% 6,017 $787K
71045 Radiologic examination, chest; single view 1.1% 21,787 $660K
99285 Emergency room visit (most serious) 1.0% 4,359 $622K
0949 <1% 18,040 $558K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 17,595 $548K
59025 Fetal non-stress test <1% 12,259 $547K
99199 Unlisted special service, procedure or report <1% 6,123 $546K
81025 <1% 22,390 $535K
J3490 Unclassified drugs <1% 54,841 $520K
80053 Comprehensive metabolic panel <1% 24,257 $516K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 29,591 $440K
80048 Basic metabolic panel (calcium, ionized) <1% 17,843 $438K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,997 $430K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 5,566 $419K
0750 <1% 1,967 $381K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 4,682 $380K
71046 Radiologic examination, chest; 2 views <1% 8,867 $373K
Z7500 <1% 10,843 $367K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 6,193 $366K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 7,389 $362K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 17,931 $337K
86850 <1% 4,189 $303K
72125 Computed tomography, cervical spine; without contrast material <1% 2,743 $296K
96375 Therapeutic injection; each additional sequential IV push <1% 12,408 $288K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 39,168 $267K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 3,565 $256K
93971 <1% 1,803 $244K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,490 $242K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,070 $236K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,345 $226K
99221 <1% 8,820 $219K
0122 <1% 107 $216K
0360 <1% 4,220 $211K
Z9725 <1% 4,643 $199K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,531 $198K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 2,385 $198K
76801 <1% 3,365 $188K
0420 <1% 2,287 $167K
0510 <1% 5,419 $159K
0720 <1% 3,591 $145K
82962 <1% 5,007 $144K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,224 $139K
99381 <1% 1,045 $133K
36415 Collection of venous blood by venipuncture <1% 8,125 $133K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 2,873 $118K
0710 <1% 4,569 $115K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 877 $114K
73130 <1% 2,175 $113K
0270 <1% 29,403 $113K
81001 <1% 24,301 $111K
83880 <1% 6,607 $111K
73030 <1% 2,007 $110K
73562 <1% 2,033 $107K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 9,003 $106K
84484 <1% 14,024 $104K
80076 <1% 6,656 $103K
73610 <1% 2,142 $101K
96361 Intravenous infusion, hydration; each additional hour <1% 5,174 $101K
73630 <1% 2,136 $101K
76830 Ultrasound, transvaginal <1% 1,766 $99K
0200 <1% 30 $96K
80047 <1% 2,744 $92K
70486 <1% 904 $91K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,721 $91K
93970 <1% 465 $90K
76813 <1% 1,629 $87K
Z1034 <1% 1,256 $87K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,718 $85K
83690 <1% 14,853 $85K
87086 Culture, bacterial; quantitative colony count, urine <1% 9,282 $83K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,043 $83K
86803 <1% 7,376 $82K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,400 $79K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,599 $79K
J7030 Infusion, normal saline solution , 1000 cc <1% 15,759 $75K
0762 <1% 1,159 $75K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 441 $75K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,880 $74K
77067 Screening mammography, bilateral, including computer-aided detection <1% 695 $74K
Z6304 <1% 2,414 $72K
81003 <1% 14,100 $72K
0760 <1% 2,556 $71K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,589 $71K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,905 $69K
97802 <1% 1,877 $61K
0636 <1% 455 $61K
73110 <1% 1,396 $59K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 611 $59K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 234 $59K
71275 Computed tomographic angiography, chest, with contrast material <1% 383 $58K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 290 $56K
Z7610 <1% 11,873 $53K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 14,081 $52K
Z6500 <1% 269 $52K
0370 <1% 1,617 $50K
90715 <1% 1,326 $50K
84702 <1% 4,271 $48K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 667 $48K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,468 $47K
85520 <1% 5,138 $46K
99213 Doctor's office visit, returning patient (routine) <1% 1,822 $46K
0160 <1% 886 $45K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,485 $44K
83605 <1% 4,413 $43K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,296 $43K
96156 <1% 554 $40K
85730 <1% 8,530 $39K
87040 <1% 2,818 $39K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,050 $38K
10060 <1% 810 $38K
85610 <1% 10,790 $37K
86900 <1% 5,270 $35K
Z1032 <1% 171 $34K
J2270 Injection, morphine sulfate, up to 10 mg <1% 8,037 $33K
93798 <1% 986 $33K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 827 $32K
73140 <1% 824 $32K
73080 <1% 686 $29K
86780 <1% 2,575 $29K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 2,520 $28K
73590 <1% 739 $27K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 739 $27K
Z6400 <1% 919 $27K
71250 <1% 197 $26K
87631 <1% 439 $26K
85027 <1% 5,486 $25K
73502 <1% 467 $25K
87077 <1% 3,160 $25K
0761 <1% 977 $23K
90714 <1% 1,358 $23K
76642 <1% 613 $23K
0171 Inj, epinephrine (belcher) <1% 67 $22K
B4160 Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit <1% 101 $22K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,143 $21K
83735 <1% 4,418 $21K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 4,348 $21K
12001 <1% 418 $20K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 392 $20K
87210 <1% 2,166 $19K
96376 <1% 1,681 $19K
74018 <1% 306 $19K
Z6406 <1% 925 $19K
77066 Tomosynthesis, mammo <1% 255 $18K
12011 <1% 293 $18K
81002 <1% 7,085 $17K
90670 <1% 2,022 $17K
73090 <1% 345 $17K
0272 <1% 1,400 $16K
J1953 Injection, levetiracetam, 10 mg <1% 353 $16K
88312 <1% 1,795 $16K
82803 <1% 1,057 $15K
Z7506 <1% 119 $15K
0424 <1% 128 $15K
73564 <1% 260 $15K
86901 <1% 5,272 $15K
Z6204 <1% 1,029 $15K
87186 <1% 1,555 $14K
73620 <1% 162 $13K
90680 <1% 1,966 $13K
76870 <1% 146 $12K
77065 Tomosynthesis, mammo <1% 170 $12K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 194 $12K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,592 $12K
84443 Thyroid stimulating hormone (TSH) <1% 1,023 $11K
70496 <1% 59 $11K
J1815 Injection, insulin, per 5 units <1% 585 $11K
A4649 Surgical supply; miscellaneous <1% 2,449 $11K
A9270 Non-covered item or service <1% 4,797 $10K
96150 <1% 441 $10K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,561 $10K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 506 $10K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 41 $10K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 114 $10K
90723 <1% 1,379 $9K
97804 <1% 1,159 $9K
J2704 Injection, propofol, 10 mg <1% 2,258 $8K
A0429 Emergency ambulance ride, basic life support <1% 251 $8K
84100 <1% 2,348 $8K
90648 <1% 1,263 $8K
29125 <1% 334 $7K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,809 $7K
99214 Doctor's office visit, returning patient (more involved) <1% 571 $7K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,905 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 835 $7K
J2060 Injection, lorazepam, 2 mg <1% 2,352 $7K
D0150 Comprehensive oral evaluation - new or established patient <1% 114 $7K
94726 <1% 229 $7K
72131 <1% 48 $6K
84145 <1% 397 $6K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 280 $6K
72110 <1% 102 $6K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,107 $6K
94729 <1% 192 $6K
36821 <1% 50 $6K
86762 <1% 336 $5K
36600 <1% 224 $5K
72170 <1% 108 $5K
85014 <1% 2,798 $5K
0721 <1% 93 $5K
70498 <1% 59 $5K
72100 <1% 82 $5K
82550 <1% 904 $5K
J2785 Injection, regadenoson, 0.1 mg <1% 29 $5K
93017 <1% 72 $5K
90710 <1% 713 $5K
96151 <1% 273 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 462 $4K
D0210 Intraoral - complete series of radiographic images <1% 86 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 561 $4K
90647 <1% 1,129 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 752 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 181 $4K
82950 <1% 677 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,024 $4K
90700 <1% 1,635 $4K
12002 <1% 81 $4K
70551 Magnetic resonance imaging, brain; without contrast material <1% 29 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,627 $3K
97803 <1% 169 $3K
Z6308 <1% 109 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,003 $3K
90713 <1% 1,042 $3K
76770 <1% 78 $3K
0430 <1% 56 $3K
G0378 Hospital observation service, per hour <1% 131 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 823 $3K
87400 <1% 184 $3K
90750 <1% 41 $2K
85379 <1% 382 $2K
81000 <1% 836 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 47 $2K
73600 <1% 26 $2K
90734 <1% 100 $2K
84439 <1% 206 $2K
80061 Lipid panel <1% 261 $2K
0258 <1% 199 $2K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 169 $2K
J3370 Injection, vancomycin hcl, 500 mg <1% 110 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 40 $2K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 826 $2K
92551 <1% 1,078 $2K
70360 <1% 14 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 229 $2K
86140 <1% 381 $2K
0305 <1% 1,068 $2K
Z6300 <1% 66 $2K
Z6200 <1% 66 $2K
0412 <1% 116 $2K
85007 <1% 908 $2K
Z6402 <1% 65 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 73 $2K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 120 $1K
90649 <1% 50 $1K
90633 <1% 964 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 41 $1K
0300 <1% 1,102 $1K
85380 <1% 303 $1K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 460 $1K
82105 <1% 232 $1K
0460 <1% 75 $1K
87522 Neg quan hep c or qual rna <1% 113 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 237 $1K
Z7512 <1% 43 $1K
82140 <1% 87 $1K
90658 <1% 151 $1K
71020 <1% 40 $948.83
90686 <1% 74 $901.30
73552 <1% 24 $879.97
J0360 Injection, hydralazine hcl, up to 20 mg <1% 128 $868.51
J1644 Injection, heparin sodium, per 1000 units <1% 237 $830.29
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 15 $804.33
0324 <1% 503 $788.64
0002A <1% 21 $778.39
82010 <1% 128 $766.11
K0001 Standard wheelchair <1% 13 $764.10
94010 <1% 28 $750.71
59425 <1% 74 $743.88
87340 <1% 357 $719.75
87081 <1% 94 $715.34
71010 <1% 54 $701.13
0031A <1% 17 $680.00
T4541 Incontinence product, disposable underpad, large, each <1% 26 $667.00
99401 <1% 170 $646.78
99070 <1% 445 $625.83
80185 <1% 28 $607.69
29515 <1% 26 $593.07
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 46 $576.20
J3486 Injection, ziprasidone mesylate, 10 mg <1% 20 $574.70
27502 <1% 36 $558.14
88142 <1% 153 $540.92
73060 <1% 27 $530.63
87147 <1% 132 $479.85
73120 <1% 12 $468.34
E1390 Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate <1% 14 $446.01
90716 <1% 170 $442.60
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 25 $421.78
S0164 Injection, pantoprazole sodium, 40 mg <1% 86 $415.59
0001A <1% 25 $398.10
84481 <1% 57 $378.91
82247 <1% 74 $357.81
J1940 Injection, furosemide, up to 20 mg <1% 83 $351.95
90707 <1% 164 $322.37
99173 <1% 786 $316.89
S0265 Genetic counseling, under physician supervision, each 15 minutes <1% 28 $315.94
Z6410 <1% 13 $313.69
J1171 Injection, hydromorphone, 0.1 mg <1% 16 $305.10
87070 <1% 27 $282.57
E0431 Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing <1% 12 $282.05
0307 <1% 421 $281.03
86580 <1% 40 $279.78
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 117 $279.15
88304 <1% 168 $274.05
94060 <1% 14 $273.39
0730 <1% 401 $264.83
0302 <1% 416 $250.20
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 30 $248.45
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study <1% 74 $223.74
85652 <1% 101 $213.29
Z6408 <1% 12 $193.44
90472 Immunization administration, each additional vaccine (list separately) <1% 112 $188.85
0306 <1% 679 $187.00
V2632 Posterior chamber intraocular lens <1% 24 $184.92
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 48 $176.49
85018 <1% 177 $161.86
Z6206 <1% 12 $145.08
S0028 Injection, famotidine, 20 mg <1% 287 $127.17
96040 <1% 27 $120.00
88342 <1% 17 $118.77
Z6412 <1% 12 $96.72
Z6306 <1% 12 $96.72
J3475 Injection, magnesium sulfate, per 500 mg <1% 27 $95.63
D0230 Intraoral - periapical each additional radiographic image <1% 23 $93.15
86592 <1% 15 $75.36
V5008 Hearing screening <1% 30 $73.03
84550 <1% 31 $70.66
90685 <1% 19 $63.00
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 24 $60.18
82248 <1% 102 $51.50
J2470 Injection, pantoprazole sodium, 40 mg <1% 19 $44.10
82728 <1% 27 $42.24
0402 <1% 85 $40.76
83540 <1% 14 $4.58
99072 <1% 16 $2.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 66 $0.00
99382 0% 112 $0.00
0320 0% 72 $0.00
0361 0% 27 $0.00
98968 0% 14 $0.00
0351 0% 39 $0.00
0489 0% 76 $0.00
E0601 Continuous positive airway pressure (cpap) device 0% 12 $0.00
0682 0% 12 $0.00
99172 0% 28 $0.00
D0120 Dental checkup, returning patient 0% 78 $0.00
0352 0% 62 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 36 $0.00
0410 0% 31 $0.00
96110 Developmental screening, with scoring and documentation, per standardized instrument 0% 78 $0.00
E0570 Nebulizer, with compressor 0% 12 $0.00
0310 0% 26 $0.00
99383 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMORISSETTE, DANIEL (CHIEF FINANCIAL OFFICER)
Parent organizationDIGNITY HEALTH
Same official

Other billing entities under MORISSETTE, DANIEL

Full network →
ProviderLocationPaid
Dignity HealthSan Bernardino, CA$133.09M
Dignity HealthPhoenix, AZ$126.19M
Dignity HealthBakersfield, CA$109.22M
Dignity HealthMerced, CA$106.54M
Dignity HealthCarmichael, CA$97.28M
Dignity HealthOxnard, CA$96.24M
Dignity HealthRedding, CA$92.21M
Dignity HealthSacramento, CA$45.52M
Dignity HealthFolsom, CA$45.14M
Dignity HealthRed Bluff, CA$39.92M
Dignity HealthSanta Cruz, CA$33.59M
Dignity HealthGilbert, AZ$28.49M
Dignity HealthGlendale, AZ$26.30M
Dignity HealthHenderson, NV$18.73M
Dignity HealthMount Shasta, CA$15.62M
Dignity HealthHenderson, NV$8.52M
Dignity HealthLas Vegas, NV$7.93M
Dignity HealthCamarillo, CA$6.31M
Dignity HealthSanta Maria, CA$5.79M
Dignity HealthCorning, CA$3.24M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.